申请人:Glunz W. Peter
公开号:US20050075376A1
公开(公告)日:2005-04-07
Compounds of Formula I are disclosed which inhibit hepatitis C NS5B RNA-dependent RNA polymerase and are useful for treating hepatitis C. Compositions and methods of using these compounds are also disclosed.
公式I的化合物被披露,可以抑制丙型肝炎NS5B RNA依赖性RNA聚合酶,并且可用于治疗丙型肝炎。还披露了使用这些化合物的组合物和方法。